These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 16277856)

  • 1. [Biological activity of C II TA anti-sense RNA--a novel approach to inhibition of rejection in transplantation].
    Guo R; Zou P; Du X; Zhag M
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):848-51. PubMed ID: 16277856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Major histocompatibility complex class II transactivator (CIITA) hammer- head ribozyme transfer inhibits major histocompatibility complex class II (MHC-II) expression in Jukart cells].
    Guo R; Zou P; Song YP; Ma J; Lu HZ; Cao YL; Tong YJ
    Zhonghua Er Ke Za Zhi; 2003 Dec; 41(12):925-8. PubMed ID: 14723817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibition effect of CIITA anti-sense cDNA on the expression of MHCII molecules of Hela cells].
    Guo R; Zou P; Fan HH; Cui L; Cao YL; Zheng B; Gao L; Gao F; Lu HZ
    Zhonghua Xue Ye Xue Za Zhi; 2003 Dec; 24(12):636-9. PubMed ID: 14761611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of anti-CII TA M1-RNA on IFN-gamma induced major histocompatibility complex class II antigens expression on cultured human chondrocytes.
    He F; Guo R; Du X; Lu ZS; Weng JY; Lin W
    Transpl Immunol; 2007 Jun; 17(4):231-6. PubMed ID: 17493524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Construction of mutants of MHC class II molecule transactivator gene capable of suppressing HLA-DR/DQ expression and exploration on their mechanism].
    Ou QS; Lin L; Huang LD; Lu PH; Zhou GY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Sep; 19(5):417-20. PubMed ID: 15169643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of allo-cell transplant rejection through CIITA ribonuclease P+ hepatocyte.
    Guo R; Zou P; Fan HH; Gao F; Shang QX; Cao YL; Lu HZ
    World J Gastroenterol; 2003 May; 9(5):1077-81. PubMed ID: 12717860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibitory effect of anti-C II TA RNase P on MHC II expression in Jurkat cells].
    He F; Wu SL; Sun M; Guo R
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):607-11. PubMed ID: 17605876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro biological activity of anti-C II TA hammerhead ribozyme--a novel approach for autoimmune diseases.
    Liu F; Zou P; Guo R; Lu H; Fan H
    J Huazhong Univ Sci Technolog Med Sci; 2003; 23(4):335-8. PubMed ID: 15015629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cloning and biological activities of riboenzymes against major histocompatibility complex class II transactivator].
    Guo R; Zou P; Yang XC; Lu HZ; Gao F; Cao YL; Zhang M; Fan HH
    Zhonghua Yi Xue Za Zhi; 2003 Apr; 83(8):669-72. PubMed ID: 12887826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL).
    Cycon KA; Rimsza LM; Murphy SP
    Exp Hematol; 2009 Feb; 37(2):184-194. PubMed ID: 19081173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The biological activity of MHC classII transactivator ribonuclease P: a novel approach for hepatic transplantation rejection].
    Guo R; Zou P; Wu SS; Cao YL; Lu HZ; Fan HH; Gao F
    Zhonghua Gan Zang Bing Za Zhi; 2003 Dec; 11(12):745-8. PubMed ID: 14697138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged MHC class II expression and CIITA transcription in human keratinocytes.
    Takagi A; Nishiyama C; Kanada S; Niwa Y; Fukuyama K; Ikeda S; Okumura K; Ogawa H
    Biochem Biophys Res Commun; 2006 Aug; 347(2):388-93. PubMed ID: 16836979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.
    Satoh A; Toyota M; Ikeda H; Morimoto Y; Akino K; Mita H; Suzuki H; Sasaki Y; Kanaseki T; Takamura Y; Soejima H; Urano T; Yanagihara K; Endo T; Hinoda Y; Fujita M; Hosokawa M; Sato N; Tokino T; Imai K
    Oncogene; 2004 Nov; 23(55):8876-86. PubMed ID: 15467734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CIITA versus IFN-gamma induced MHC class II expression in head and neck cancer cells.
    Meissner M; Whiteside TL; Kaufmann R; Seliger B
    Arch Dermatol Res; 2009 Feb; 301(2):189-93. PubMed ID: 19104823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of MHC DR nonexpression on swine cells by introduction of a mutated MHC class II transactivator gene: a comparison with the effect induced by antisense RNA.
    Ou Q; Lin L; Huang L; Chen F; Wu K; Lu P; Zhang J; Chou KY
    J Clin Immunol; 2004 Jan; 24(1):97-106. PubMed ID: 14997039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
    Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
    Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon.
    Baudeau C; Delarue F; Hé CJ; Nguyen G; Adida C; Peraldi MN; Sraer JD; Rondeau E
    Exp Nephrol; 1994; 2(5):306-12. PubMed ID: 7812737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of class II transactivator with HLA-DR antigen and its implications.
    Xu KL; Li H; Pan XY; Li ZY; Lu QX; Zhang Y; Zhu HH; DU B; Zeng LY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):147-51. PubMed ID: 17490542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization.
    Muczynski KA; Anderson SK; Pious D
    J Immunol; 1998 Apr; 160(7):3207-16. PubMed ID: 9531276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a specific post-transcriptional mechanism controlling the expression of HLA-DQ, but not -DR and -DP, molecules.
    De Lerma Barbaro A; Sartoris S; Tosi G; Nicolis M; Accolla RS
    J Immunol; 1994 Nov; 153(10):4530-8. PubMed ID: 7525708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.